Comparative between eravacycline and best available therapy in carbapenem-resistant Acinetobacter baumannii HAP/VAP in China: a retrospective real-world multicenter cohort study

Objectives: Carbapenem-resistant Acinetobacter baumannii (CRAB) is a major cause of hospital- and ventilator-associated pneumonia (HAP/VAP) with limited treatment options. Eravacycline (ERA) shows potent in vitro activity and favorable pulmonary pharmacokinetics, but clinical evidence for CRAB HAP/V...

Descripció completa

Dades bibliogràfiques

Autors principals:	Huangdu Hu, Yifeng Luo, Meijun Song, Xiaoju Zhang, Min He, Xiangyan Liu, Chun Pan, Lingai Pan, Xiaojing Li, Xianyao Wan, Kun Chen, Wei Cui, Shiting Zhou, Shutao Zou, Jintao He, Haiyang Liu, Xiaoting Hua, Xiaoxing Du, Xi Li, Zhenguo Zeng, Yunsong Yu
Format:	Artigo
Idioma:	Inglês
Publicat:	Elsevier 2026-08-01
Col·lecció:	International Journal of Infectious Diseases
Matèries:	Eravacycline Carbapenem-resistant Acinetobacter baumannii HAV/VAP
Accés en línia:	http://www.sciencedirect.com/science/article/pii/S1201971226003930
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!